7 studies were found.

1.		Recruiting	Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated with the Epstein Barr Virus Conditions: Cancer; grade I lymphomatoid granulomatosis; grade II lymphomatoid granulomatosis; recurrent grade I lymphomatoid granulomatosis; ...
2.		Recruiting	Treatment and Natural History Study of Lymphomatoid Granulomatosis Condition: Lymphomatoid Granulomatosis
3.		Recruiting	Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma Conditions: recurrent adult Hodgkin's lymphoma; recurrent adult Burkitt's lymphoma; post-transplant lymphoproliferative disorder; ...
4.		Not yet recruiting	Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer Conditions: Cachexia; Cancer; Pain
5.		Recruiting	Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction Conditions: adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor
6.		Recruiting	Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy Conditions: adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
7.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ...